SLNSW-Avelumab for metastatic or locally advanced previ...-TN_cdi_proquest_journals_1895872979

Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

Full title: Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

Author/creator: Heery, Christopher R, MD, O'Sullivan-Coyne, Geraldine, MD, Madan, Ravi A, MD, Cordes, Lisa, PhD, Rajan, Arun, MD, Rauckhorst, Myrna, RN, Lamping, Elizabeth, RN, Oyelakin, Israel, RN, Marté, Jennifer L, MD, Lepone, Lauren M, PhD, Donahue, Renee N, PhD, Grenga, Italia, PhD, Cuillerot, Jean-Marie, MD, Neuteboom, Berend, PhD, Heydebreck, Anja von, PhD, Chin, Kevin, MD, Schlom, Jeffrey, PhD, Gulley, James L, Dr.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_1895872979

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1895872979

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

    Record identifier

    TN_cdi_proquest_journals_1895872979

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1895872979

    Share

    Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1895872979

    Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

    Full title

    Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

    Author / Creator

    Heery, Christopher R, MD ; O'Sullivan-Coyne, Geraldine, MD ; Madan, Ravi A, MD ; Cordes, Lisa, PhD ; Rajan, Arun, MD ; Rauckhorst, Myrna, RN ; Lamping, Elizabeth, RN ; Oyelakin, Israel, RN ; Marté, Jennifer L, MD ; Lepone, Lauren M, PhD ; Donahue, Renee N, PhD ; Grenga, Italia, PhD ; Cuillerot, Jean-Marie, MD ; Neuteboom, Berend, PhD ; Heydebreck, Anja von, PhD ; Chin, Kevin, MD ; Schlom, Jeffrey, PhD ; Gulley, James L, Dr

    Publisher

    England: Elsevier Ltd

    Journal title

    The lancet oncology, 2017, Vol.18 (5), p.587-598

    Record Identifier

    TN_cdi_proquest_journals_1895872979

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Abdominal Pain - chemically induced Aged Amylases - blood Analysis Antibodies Antibodies - blood Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - immunology Antibodies, Monoclonal - pharmacokinetics Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Agents - immunology Antineoplastic Agents - pharmacokinetics Aspartate aminotransferase Aspartate Aminotransferases - blood Autoimmune Diseases - chemically induced Blood Cancer Cancer therapies Cell number Chills - chemically induced Clinical trials Creatine Creatine kinase Creatine Kinase - blood Cytotoxicity Drug dosages Dysphonia - chemically induced Fatigue Fatigue - chemically induced FDA approval Female Fever Fever - chemically induced Half-Life Hematology, Oncology and Palliative Medicine Humans Immunoglobulin G Immunoglobulins Immunology Immunotherapy Influenza Intravenous administration Lung cancer Lymphocytes T Male Medical research Medicine, Experimental Melanoma Metastases Metastasis Middle Aged Monoclonal antibodies Myositis Myositis - chemically induced Neoplasms - drug therapy Pain Patients PD-1 protein PD-L1 protein Pharmacodynamics Pharmacokinetics Response Evaluation Criteria in Solid Tumors Rodents Studies T cells Targeted cancer therapy Toxicity Tumors

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_1895872979

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1895872979

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections